Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × Anti-Bacterial Agents × Clear all

NCT05462496 2024-10-15

Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer

Phase 2 Recruiting

Gastrointestinal

Pancreatic Neoplasms